220 related articles for article (PubMed ID: 35795285)
1. Pharmacological Activities of Safflower Yellow and Its Clinical Applications.
Chen Y; Li M; Wen J; Pan X; Deng Z; Chen J; Chen G; Yu L; Tang Y; Li G; Xie X; Peng C
Evid Based Complement Alternat Med; 2022; 2022():2108557. PubMed ID: 35795285
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
[TBL] [Abstract][Full Text] [Related]
3. Composition of major quinochalcone hydroxysafflor yellow A and anhydrosafflor yellow B is associated with colour of safflower (Carthamus tinctorius) during colour-transition but not with overall antioxidant capacity: A study on 144 cultivars.
Yan Z; Alimu R; Wan J; Liao X; Lin S; Dai S; Chen F; Zhang S; Tong Y; Liu H; Qin R; Liu J
Food Res Int; 2022 Dec; 162(Pt B):112098. PubMed ID: 36461404
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology.
Zhang Y; Yu L; Jin W; Li C; Wang Y; Wan H; Yang J
Molecules; 2020 Mar; 25(5):. PubMed ID: 32182800
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis
Fangma Y; Zhou H; Shao C; Yu L; Yang J; Wan H; He Y
Front Pharmacol; 2021; 12():739864. PubMed ID: 34658877
[TBL] [Abstract][Full Text] [Related]
6. Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liver and Adipose Tissue.
Yan K; Wang X; Pan H; Wang L; Yang H; Liu M; Zhu H; Gong F
Front Pharmacol; 2020; 11():482. PubMed ID: 32372961
[TBL] [Abstract][Full Text] [Related]
7. Three Ingredients of Safflower Alleviate Acute Lung Injury and Inhibit NET Release Induced by Lipopolysaccharide.
Wang YP; Guo Y; Wen PS; Zhao ZZ; Xie J; Yang K; Yang Q; Wang JF; Deng XM
Mediators Inflamm; 2020; 2020():2720369. PubMed ID: 32189992
[TBL] [Abstract][Full Text] [Related]
8. Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation.
Yao D; Wang Z; Miao L; Wang L
J Ethnopharmacol; 2016 Sep; 191():264-272. PubMed ID: 27286914
[TBL] [Abstract][Full Text] [Related]
9. Safflower yellow and its main component hydroxysafflor yellow A alleviate hyperleptinemia in diet-induced obesity mice through a dual inhibition of the GIP-GIPR signaling axis.
Lyu X; Yan K; Hu W; Xu H; Guo X; Zhou Z; Zhu H; Pan H; Wang L; Yang H; Gong F
Phytother Res; 2023 Mar; ():. PubMed ID: 36943416
[TBL] [Abstract][Full Text] [Related]
10. Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.
Lyu X; Yan K; Xu H; Zhu H; Pan H; Wang L; Yang H; Gong F
Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):579-591. PubMed ID: 35201390
[TBL] [Abstract][Full Text] [Related]
11. Safflower Yellow Improves the Synaptic Structural Plasticity by Ameliorating the Disorder of Glutamate Circulation in Aβ
Hou J; Wang C; Zhang M; Ren M; Yang G; Qu Z; Hu Y
Neurochem Res; 2020 Aug; 45(8):1870-1887. PubMed ID: 32410043
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects.
Zhao F; Wang P; Jiao Y; Zhang X; Chen D; Xu H
Front Pharmacol; 2020; 11():579332. PubMed ID: 33536906
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant and Pro-Oxidant Properties of Carthamus Tinctorius, Hydroxy Safflor Yellow A, and Safflor Yellow A.
Bacchetti T; Morresi C; Bellachioma L; Ferretti G
Antioxidants (Basel); 2020 Jan; 9(2):. PubMed ID: 32013224
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A and anhydrosafflor yellow B alleviate ferroptosis and parthanatos in PC12 cells injured by OGD/R.
Chen G; Li C; Zhang L; Yang J; Meng H; Wan H; He Y
Free Radic Biol Med; 2022 Feb; 179():1-10. PubMed ID: 34923102
[TBL] [Abstract][Full Text] [Related]
15. Safflower yellow improves insulin sensitivity in high-fat diet-induced obese mice by promoting peroxisome proliferator-activated receptor-γ2 expression in subcutaneous adipose tissue.
Yan K; Wang X; Zhu H; Pan H; Wang L; Yang H; Liu M; Jin M; Zang B; Gong F
J Diabetes Investig; 2020 Nov; 11(6):1457-1469. PubMed ID: 32356607
[TBL] [Abstract][Full Text] [Related]
16. Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota.
Fu H; Liu X; Jin L; Lang J; Hu Z; Mao W; Cheng C; Shou Q
Food Funct; 2021 Nov; 12(21):10632-10643. PubMed ID: 34585698
[TBL] [Abstract][Full Text] [Related]
17. Safflower yellow alleviates osteoarthritis and prevents inflammation by inhibiting PGE2 release and regulating NF-κB/SIRT1/AMPK signaling pathways.
Wang C; Gao Y; Zhang Z; Chi Q; Liu Y; Yang L; Xu K
Phytomedicine; 2020 Nov; 78():153305. PubMed ID: 32871523
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity, clinical uses, and phytochemical and pharmacological properties of safflower (
Cheng H; Yang C; Ge P; Liu Y; Zafar MM; Hu B; Zhang T; Luo Z; Lu S; Zhou Q; Jaleel A; Ren M
Front Pharmacol; 2024; 15():1374680. PubMed ID: 38799156
[TBL] [Abstract][Full Text] [Related]
19. Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study.
Shi P; Ruan Y; Zhong C; Teng L; Ke L; Yao H
Front Pharmacol; 2022; 13():1062026. PubMed ID: 36506545
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Fluorescence Sensitization Method for Hydroxysafflor Yellow A.
Haiyan C; Xiude Q; Chen L; Xinzhe Z; Yuhui MA; Jingna Z; Yu L; Shaoqin GE; Guowei Z; Hailiang N
Evid Based Complement Alternat Med; 2020; 2020():3027843. PubMed ID: 32419799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
